PUBLIC HEALTH INFORMATION

The Food and Drug Administration (FDA) has granted an emergency use authorization (EUA) for a promising new drug cocktail for hospitalized CCP virus patients. The treatment involves combining remdesivir with the ...

A recent study on surgical mask-wearing found no significant difference in CCP virus infections between those who wore ...

Health and Human Services Secretary Alex Azar said Thursday that Pfizer and its partner BioNTech would file for ...

A nasal spray that slows CCP (Chinese Communist Party) virus infection has been developed by researchers at the ...

With a COVID-19 vaccine possibly rolling out to the public by December or early next year, some governments ...

One of the leading COVID-19 vaccine candidates was 94 percent effective in adults older than 65, according to ...

A vaccine candidate jointly developed by Moderna and the National Institutes of Health (NIH) has been shown in ...

Eight months into the pandemic and without much guidance from federal health agencies on therapies for COVID-19, doctors ...

A new study suggests that T cells, a type of white blood cell, may be sufficient to protect ...

With over 43,500 volunteers taking part in Pfizer's COVID-19 vaccine trial, reports have emerged of people who took ...

The CDC issued a report Tuesday saying that wearing a mask can protect both the wearer and those ...

U.S. drug regulators granted Eli Lilly’s COVID-19 antibody drug an emergency-use authorization on Monday, widening access to a ...

Pfizer and German partner BioNTech say their COVID-19 vaccine candidate is proving to be strongly effective in a ...

The U.S. Centers for Disease Control and Prevention (CDC) issued updated guidance Monday saying that voters infected with ...

The Centers for Disease Control and Prevention (CDC) issued a conditional sailing order (pdf) for cruise ships on ...

The Centers for Disease Control and Prevention (CDC) updated its guidance for investigating probable COVID-19 reinfections in response to ...

The National Institute of Allergy and Infectious Diseases (NIAID) announced in a statement that they have stopped clinical trials of ...

Child care programs that remained open during the early months of the CCP virus pandemic did not contribute ...

A new study (pdf) indicates that the CCP Virus could cause a patient’s immune system to attack the ...

AstraZeneca's CCP virus vaccine is producing an encouraging immune response among both older and younger adults, the drugmaker ...

AstraZeneca has resumed the U.S. trial of its experimental COVID-19 vaccine after approval by regulators, and Johnson & ...

Two recent studies found that the rate of mortality has been dropping for hospitalized COVID-19 patients. One of ...

Physicians say they are concerned about the National Institutes of Health’s (NIH) updated guidance on therapeutics for COVID-19 ...

The U.S. Food and Drug Administration on Thursday approved Gilead Sciences's antiviral drug remdesivir for the treatment of adults ...

A volunteer in AstraZeneca's COVID-19 vaccine trial died in Brazil, the country's health authority confirmed Wednesday. Anvisa, the authority, ...

News Analysis Since the beginning of the CCP (Chinese Communist Party) virus pandemic, policymakers in the United States have relied ...